You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VX15-984-001

Showing 1 - 25 of 936
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

Recruiting
  • Non-Cystic Fibrosis Bronchiectasis
  • Brensocatib 10 mg
  • +2 more
  • Birmingham, Alabama
  • +416 more
Jan 24, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in Atlanta (VX15/2503, Ipilimumab, Nivolumab)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • VX15/2503
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital Midtown
Mar 2, 2022

NSCLC Trial in United States (VX15/2503 + avelumab)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • VX15/2503 + avelumab
  • Fayetteville, Arkansas
  • +10 more
Apr 25, 2022

Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

Recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Ipilimumab
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 11, 2022

Gastroparesis Trial in United States (CNSA-001, Placebo)

Completed
Has Results
  • Gastroparesis
  • Chula Vista, California
  • +5 more
Dec 7, 2021

Colon Carcinoma Metastatic in the Liver, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Atlanta, Rochester

Active, not recruiting
  • Colon Carcinoma Metastatic in the Liver
  • +13 more
  • Anti-SEMA4D Monoclonal Antibody VX15/2503
  • +3 more
  • Atlanta, Georgia
  • +3 more
Dec 15, 2021

Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))

Completed
  • Safety
  • +2 more
  • RHN-001 (one tablet 750mg)
  • RHN-001 (750mg * 2 Tablets)
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research (CBSCR),
Apr 26, 2023

l Gene Editing Therapy for Cardiovascular Disease

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
    • Auckland, New Zealand
    • +2 more
    Oct 31, 2023

    Advanced Solid Tumor Trial in Shanghai (B4T2-001 autologous CAR-T)

    Recruiting
    • Advanced Solid Tumor
    • B4T2-001 autologous CAR-T
    • Shanghai, China/Shanghai, China
    • +1 more
    Oct 3, 2023

    Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

    Not yet recruiting
    • Acneiform Eruption Due to Chemical
    • +2 more
    • HT-001 2% Topical Gel
    • +3 more
    • (no location specified)
    Dec 3, 2022

    Cystic Fibrosis Trial (VX-828, Placebo, Itraconazole)

    Not yet recruiting
    • Cystic Fibrosis
    • (no location specified)
    Nov 23, 2023

    Non-Hodgkin Lymphoma Trial (CC-122, Dexamethasone)

    Not yet recruiting
    • Non-Hodgkin Lymphoma
    • (no location specified)
    Jan 10, 2023

    Cystinosis Trial (Cysteamine Bitartrate, N-Acetylcysteine Amide)

    Not yet recruiting
    • Cystinosis
    • Cysteamine Bitartrate
    • N-Acetylcysteine Amide
    • (no location specified)
    Aug 15, 2023

    Meibomian Gland Dysfunction, Dry Eye Trial in Australia, Canada, New Zealand (AZR-MD-001 Low Dose, AZR-MD-001 Mid Dose,

    Completed
    • Meibomian Gland Dysfunction
    • Dry Eye
    • AZR-MD-001 Low Dose
    • +3 more
    • Chatswood, New South Wales, Australia
    • +29 more
    Nov 23, 2022

    Acute Cannabinoid Intoxication Trial in Leiden (ANEB-001, Placebo)

    Active, not recruiting
    • Acute Cannabinoid Intoxication
    • Leiden, ZH, Netherlands
      Centre for Human Drug Research (CHDR)
    Jan 31, 2023

    Vaccine-Preventable Diseases, Herpes Zoster Trial in Seoul, Seongnam-si (CVI-VZV-001, Shingrix)

    Recruiting
    • Vaccine-Preventable Diseases
    • Herpes Zoster
    • CVI-VZV-001
    • Shingrix
    • Seoul, Eunpyeong-gu, Korea, Republic of
    • +1 more
    Nov 20, 2023

    Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

    Recruiting
    • Astrocytoma, Grade IV
    • +3 more
    • CYNK-001 systemic and Intra cavity administration
    • Duarte, California
    • +5 more
    Jan 20, 2023

    Atopic Dermatitis Trial in Beijing (GD-iExo-001, normal saline)

    Recruiting
    • Atopic Dermatitis
    • Beijing, Beijing, China
      Chinese Academy of Medical Science & Peking Union Medical Colleg
    Jul 23, 2023

    Oral Mucositis Trial (RRx-001, Intensity Modulated Radiation Therapy (IMRT), Cisplatin for injection 100 mg/m2)

    Not yet recruiting
    • Oral Mucositis
    • (no location specified)
    Jul 31, 2023

    Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • +4 more
    • Birmingham, United Kingdom
    • +5 more
    Sep 18, 2023

    Solid Tumor Trial in Houston (IMGS-001)

    Recruiting
    • Solid Tumor
    • Houston, Texas
      MD Anderson Cancer Center
    Aug 23, 2023

    Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)

    Not yet recruiting
    • Thyroid Eye Disease
    • VRDN-001 10 mg/kg Drug:
    • (no location specified)
    Sep 7, 2023

    Healthy Trial (K-001, K-877-ER, CSG452)

    Not yet recruiting
    • Healthy
    • (no location specified)
    Feb 1, 2023

    Major Depression, Post Traumatic Stress Disorder Trial in Seattle (SM-001)

    Not yet recruiting
    • Major Depression
    • Post Traumatic Stress Disorder
    • Seattle, Washington
      AIMS Institute
    Jun 13, 2023

    Ureter Injury Trial (IS-001)

    Not yet recruiting
    • Ureter Injury
    • (no location specified)
    Jul 13, 2023